chr3-38771279-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_006514.4(SCN10A):c.599C>T(p.Ala200Val) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000193 in 1,613,778 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006514.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN10A | NM_006514.4 | c.599C>T | p.Ala200Val | missense_variant, splice_region_variant | 5/28 | ENST00000449082.3 | NP_006505.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN10A | ENST00000449082.3 | c.599C>T | p.Ala200Val | missense_variant, splice_region_variant | 5/28 | 1 | NM_006514.4 | ENSP00000390600.2 | ||
SCN10A | ENST00000643924.1 | c.599C>T | p.Ala200Val | missense_variant, splice_region_variant | 4/27 | ENSP00000495595.1 | ||||
SCN10A | ENST00000655275.1 | c.599C>T | p.Ala200Val | missense_variant, splice_region_variant | 5/28 | ENSP00000499510.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251336Hom.: 0 AF XY: 0.000147 AC XY: 20AN XY: 135818
GnomAD4 exome AF: 0.000202 AC: 295AN: 1461552Hom.: 1 Cov.: 31 AF XY: 0.000199 AC XY: 145AN XY: 727060
GnomAD4 genome AF: 0.000112 AC: 17AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74428
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | SCN10A: PS3:Supporting - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 24, 2024 | BS2, PP3 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 24, 2024 | Reported in a patient with the type 1 Brugada pattern on ECG; however, it did not segregate with two other relatives who also had the same ECG findings (PMID: 25691538); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30662450, 30821013, 25691538) - |
Brugada syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Brugada syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 25, 2022 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 200 of the SCN10A protein (p.Ala200Val). This variant is present in population databases (rs554062977, gnomAD 0.01%). This missense change has been observed in individual(s) with Brugada syndrome and sudden death, in which it was not described to segregate with disease, as well as in two healthy control subjects (PMID: 25691538). ClinVar contains an entry for this variant (Variation ID: 565891). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SCN10A function (PMID: 25691538). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at